Long non-coding RNAs are significantly associated with prognosis and response to therapies in gastric cancer

Clin Transl Med. 2021 Jun;11(6):e421. doi: 10.1002/ctm2.421.
No abstract available

Keywords: ZNF667-AS1; chemotherapy; gastric cancer; immunotherapy; long non-coding RNA (lncRNA); prognosis.

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / genetics*
  • Chemotherapy, Adjuvant / mortality*
  • Follow-Up Studies
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Immune Checkpoint Inhibitors / therapeutic use*
  • Prognosis
  • RNA, Long Noncoding / genetics*
  • Retrospective Studies
  • Stomach Neoplasms / drug therapy
  • Stomach Neoplasms / genetics
  • Stomach Neoplasms / pathology*
  • Survival Rate

Substances

  • Biomarkers, Tumor
  • Immune Checkpoint Inhibitors
  • RNA, Long Noncoding